semaglutide

Novo Ends Semaglutide Kidney Study Early Due to Strong Efficacy Signals

BioSpace

Wed, 10/11/23 - 10:15 am

Novo Nordisk

semaglutide

clinical trials

diabetes

chronic kidney disease

Inside the FDA's Form 483 findings at Novo Nordisk's North Carolina semaglutide plant

Fierce Pharma

Tue, 09/19/23 - 10:19 pm

After treatment with semaglutide, people with newly diagnosed type 1 diabetes needed little or no insulin

Medical News Today

Sun, 09/10/23 - 08:03 pm

Obesity: Six trials to watch over the next 12 months

Clinical Trials Arena

Fri, 06/30/23 - 11:45 am

Novo Nordisk says EMA raised safety signal on drugs including semaglutide

Yahoo/Reuters

Thu, 06/22/23 - 10:21 am

Eli Lilly's Mounjaro is primed to surpass Novo Nordisk's popular diabetes and obesity duo: report

Fierce Pharma

Mon, 06/19/23 - 10:29 am

Novo Nordisk’s trial of oral semaglutide meets primary endpoint

Clinical Trials Arena

Tue, 05/23/23 - 09:56 am

Novo Nordisk's GLP-1 for Type II diabetes approved for first-line treatment

Endpoints

Fri, 01/13/23 - 11:10 am

A pharmaceutical jack of all trades? Novo CEO touts semaglutide's potential in NASH, Alzheimer's and its hot start in obesity

Fierce Pharma

Mon, 08/29/22 - 10:40 am

Novo Nordisk successfully completes phase 2 trial with CagriSema in people with type 2 diabetes

Yahoo Finance

Mon, 08/22/22 - 10:00 am

After phase 2 flop, Novo Nordisk says its NASH work is 'still very much on track'

Fierce Pharma

Wed, 06/29/22 - 05:43 pm

Novo Nordisk

NASH

semaglutide

Novo Nordisk, armed with Wegovy green light, preps aggressive push to build obesity market

Fierce Pharma

Tue, 06/8/21 - 12:21 pm

Novo Nordisk's semaglutide set to tackle obesity with hotly-anticipated FDA green light

Fierce Pharma

Sat, 06/5/21 - 02:26 pm

Go or no go? Aducanumab’s day of reckoning

EP Vantage

Thu, 05/27/21 - 10:56 am

Novo Nordisk to launch PhIII obesity trial for oral semaglutide

Endpoints

Wed, 04/21/21 - 11:17 pm

FDA Asks Novo Nordisk For More Information On Semaglutide Label Expansion Application

Benzinga

Tue, 03/23/21 - 10:25 am

Lilly's tirzepatide beats Novo's semaglutide in diabetes phase 3, but another study muddies picture

Fierce Biotech

Thu, 03/4/21 - 10:05 am

Novo Nordisk's blockbuster diabetes drug blows the doors off in obesity, proving highly effective in driving weight loss

Endpoints

Thu, 02/11/21 - 10:43 am

Novo Nordisk

semaglutide

obesity

Novo Nordisk files for regulatory approval in the US of once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes

Yahoo/Global Newswire

Wed, 01/20/21 - 10:39 am

Gilead and Novo plot next steps after trial data from NASH combo

Pharmaforum

Mon, 11/16/20 - 10:19 am

Search form

You are here

semaglutide

Pages